233250 fundamentals
Key facts
Median Diagnostics Inc. engages in the manufacture and supply of in vitro diagnostic products for animal diseases and raw materials for human disease diagnosis. It operates through the following business divisions: Immunological Diagnosis, Molecular Diagnostics, POCT Diagnosis, and Biologicals. The Immunological Diagnosis business division focuses on fluorescent labels, enzymes, and other chemical indicators to detect and quantify the analyte. The Molecular Diagnostics business division refers to tests for unique nucleic acid sequences present in pathogenic microorganisms. The POCT Diagnosis business division consists of rapid kits for human and animal diagnostics. The Biologicals business division includes raw materials for human and animal diagnostics. The company was founded on October 18, 1999 and is headquartered in Chuncheon-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company